Are bone scintigraphy examinations requested in oncologic patients according to established indications?

To determine the percentage of bone scintigraphy examinations (BS) requested according to established indications and to assess the clinical impact of the scintigraphic results. A retrospective study was performed including BS in 117 patients (70 women and 47 men) carried out in our department during the year 2001. All patients had a primary extraosseous malignancy. The correctness of the indication of each study requested was analyzed according to established criteria from the literature. BS results were classified as positive, negative, and equivocal for metastatic disease. 96 out of the 117 BS were performed in patients affected with the most prevalent primary malignancies: breast (57), prostate (21), and lung (18). The remaining studies were included in a miscellaneous group (gynecological [3], colorectal [4], oropharyngeal [4], and renal malignancies [4]; lymphoma [2], melanoma [2], hemangioendothelioma [1]; and cancer of the bladder [1] or pancreas [1]). Ninety-nine (85%) of the 117 BS performed met the criteria for appropriate indication. The indication was correct in 75% of breast, 90% of prostate (19/21), and 100% of lung cancers. The indication was correct in 90% of the cases in the miscellaneous group. BS were positive in 21 patients (20 of which were confirmed). BS were equivocal in 24 patients (in 5 of whom bone metastases were confirmed). BS were negative in 72 patients (one of whom had bone metastases). The BS findings changed staging in 9% (9/99) of the correctly indicated cases. Most BS (85%) were indicated according to the established criteria and the clinical impact was greater in this group. Determinar el porcentaje de gammagrafías óseas (GO) solicitadas, según indicaciones consensuadas y valorar el impacto clínico del resultado gammagráfico. Se realizó un estudio retrospectivo de 117 GO (70 mujeres y 47 varones) que fueron realizadas en nuestro servicio en el 2001. Todos tenían cáncer primario extraóseo. Para evaluar la correcta indicación de las GO solicitadas se analizaron los criterios según la literatura. Los resultados gammagráficos se clasificaron en: positivo, negativo y dudoso para metástasis. De las 117 GO estudiadas, 96 pertenecieron a los cánceres más prevalentes (57 de mama, 21 de próstata y 18 de pulmón). El resto se incluyeron en el grupo miscelánea (3 ginecológicos, 4 colorrectal, 3 orofaringe, 4 renales, 2 linfomas, 2 melanomas, uno de páncreas, uno de vejiga y un hemangioendotelioma). El 85% de las GO solicitadas tenía